Gary Nachman

Director, Specialty Pharmaceuticals

Gary Nachman joined Leerink Swann in 2005 as Director of Specialty Pharmaceuticals. Prior to joining Leerink Swann, Mr. Nachman was in Equity Research at Morgan Stanley for five years where he was a member of the Institutional Investor ranked research team covering Specialty Pharmaceuticals and was lead analyst on some of the smaller cap names there. Previously, Mr. Nachman spent three years at Merck-Medco as manager of the Financial Evaluations Group. Before returning to business school, he worked for three years as a CPA at Ernst & Young. He received his B.S. in Accounting from Binghamton University in New York and his MBA from Columbia University.